Lessons learned from New Zealand's ‘genomic journey’ through the COVID-19 pandemic

Publicly released:
New Zealand
Image by fusion medical animation on UnSplash
Image by fusion medical animation on UnSplash

New Zealand scientists at the forefront of our COVID-19 pandemic response say the lessons learned from our world-leading genomic surveillance programmes could be useful in the looming crisis of antimicrobial resistance, and in monitoring other infectious diseases. They say speed was key to New Zealand’s effective use of genomic data during the pandemic, but more training is needed so that people can effectively weave genomic data into their decision-making. On top of patient swabs and wastewater monitoring, they argue that the detection of diseases on surfaces, in the air, and within our animal populations is needed to build a genomic surveillance system with as few gaps as possible.

Attachments

Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.

Research Springer Nature, Web page
Journal/
conference:
BMC Medicine
Research:Paper
Organisation/s: ESR (Institute of Environmental Science and Research Ltd), University of Otago, University of Auckland, Department of Conservation, Te Pūnaha Matatini
Funder: N/A
Media Contact/s
Contact details are only visible to registered journalists.